Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity. Chow EW, Chow E. Lancet 2026;406:2866-2868.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chow EW, Chow E. Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity. Lancet 2026;406:2866-2868.
PMID: 41421831